Anavex: ANAVEX 3-71 Could Potentially Offer Disease-Modifying Effects For Schizophrenia

Anavex Life Sciences reported positive phase 2 results for ANAVEX 3-71 in schizophrenia. Read my analysis on AVXL stock here.